ongo
novel
coronaviru
pneumonia
outbreak
wuhan
china
engend
numer
case
infect
death
diagnosi
reli
upon
nucleic
acid
detect
howev
current
recommend
method
exhibit
high
falseneg
rate
low
sensit
identifi
respiratori
viru
infect
therebi
result
patient
misdiagnosi
imped
epidem
contain
combin
advantag
target
amplif
longread
realtim
nanopor
sequenc
develop
nanopor
target
sequenc
nt
detect
ongo
novel
coronaviru
pneumonia
decemb
subsequ
spread
across
china
worldwid
result
numer
case
infect
death
usual
incub
period
day
obviou
symptom
time
viru
spread
infect
uninfect
individu
therefor
earli
accur
diagnosi
isol
patient
key
control
epidem
nucleic
acid
detect
golden
standard
diagnosi
realtim
revers
transcriptionpolymeras
chain
reaction
qpcr
recommend
test
method
detect
caus
viru
qpcr
specif
rapid
econom
precis
analyz
amplifi
gene
fragment
nucleic
acid
sequenc
thu
posit
infect
confirm
monitor
one
two
site
depend
manufactur
guidelin
howev
qpcr
exhibit
high
falseneg
rate
low
sensit
clinic
applic
posit
detect
ratio
falseneg
facilit
epidem
spread
delay
patient
isol
treatment
patient
mistakenli
consid
uninfect
cure
follow
misdiagnos
treatment
result
anoth
recommend
detect
method
sequenc
wide
appli
pathogen
identif
monitor
viru
evolut
includ
requir
expens
equip
oper
expertis
h
turnaround
time
render
unsuit
current
crisi
sever
intellig
method
rna
viru
detect
develop
includ
combin
toehold
switch
sensor
bind
sens
virtual
rna
sequenc
paperbas
cellfre
protein
synthesi
ebola
zika
viru
detect
sherlock
method
base
zika
dengu
viru
detect
rapid
sherlock
method
visual
result
detect
toehold
switch
biosensor
could
theoret
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
aa
aa
protein
also
consid
rnadepend
rna
polymeras
rdrp
region
fig
virul
region
fragment
bp
design
target
fulli
cover
bp
region
amplifi
specif
primer
design
consid
primerprim
interact
anneal
temperatur
potenti
specif
bind
human
common
bacterium
fungi
genom
improv
sensit
region
amplif
design
two
pair
nest
primer
amplifi
bp
region
avoid
amplif
failur
owe
site
mutat
final
primer
combin
develop
primer
panel
supplementari
tabl
sequenc
chose
nanopor
platform
could
sequenc
long
nucleic
acid
fragment
simultan
analyz
dataoutput
realtim
allow
confirm
infect
within
minut
sequenc
map
sequenc
read
genom
analysi
output
sequenc
ident
coverag
read
number
moreov
accur
nucleic
acid
sequenc
gener
use
pipelin
could
indic
whether
relat
gene
mutat
viru
spread
therebi
rapidli
provid
inform
subsequ
epidemiolog
analysi
addit
minion
nanopor
sequenc
portabl
nt
also
suitabl
frontlin
clinic
nt
result
interpret
limit
detect
lod
test
detect
effici
nt
use
standard
plasmid
harbor
viru
n
gene
simul
standard
plasmid
individu
spike
background
cdna
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
sampl
cdna
reversetranscrib
uninfect
respiratori
flora
throat
swab
copiesml
nt
test
sampl
perform
one
minion
sequenc
chip
sequenc
data
evalu
regular
interv
use
inhous
bioinformat
pipelin
map
output
read
genom
read
high
ident
calcul
plasmid
concentr
min
h
sequenc
data
read
map
significantli
differ
neg
control
replic
concentr
rang
fig
fig
copiesml
respect
result
confirm
highcopi
sampl
could
rapidli
yield
suffici
valid
sequenc
data
diagnosi
extend
sequenc
time
valid
sequenc
data
could
also
obtain
lowcopi
sampl
notabl
sequenc
data
could
achiev
addit
sequenc
time
evalu
target
distribut
valid
data
reveal
higher
copi
sampl
copiesml
target
region
could
detect
fig
howev
lower
viral
concentr
sampl
copiesml
target
region
lost
ie
read
map
fig
indic
lowqual
lowabund
sampl
comprehens
fragment
amplif
difficult
therefor
accur
result
nt
label
sampl
posit
infect
monitor
one
two
site
customari
qpcr
rather
result
target
region
consid
accordingli
determin
score
rule
refer
previou
judgment
rule
firstli
count
number
output
read
high
ident
genom
indic
high
credibl
identif
calcul
ratio
count
valid
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
read
number
test
sampl
neg
control
neg
control
calcul
defin
ratio
indic
posit
result
fragment
score
fold
inconclus
score
neg
score
score
sum
obtain
nt
score
consid
sampl
least
fragment
fragment
inconclus
fragment
posit
compar
qpcr
result
could
defin
posit
infect
sampl
eg
nt
score
inconclus
fragment
posit
fragment
indic
highli
suspect
inconclus
sampl
eg
nt
score
inconclus
posit
fragment
could
defin
neg
sampl
nt
score
determin
nt
lod
use
defin
rule
evalu
replic
simul
test
standard
plasmid
contain
design
fragment
half
design
fragment
defin
score
nt
score
indic
posit
detect
inconclus
reflect
neg
detect
calcul
score
lowest
concentr
copi
differ
time
accord
score
method
judg
posit
detect
rate
result
supplementari
tabl
show
copi
standard
plasmid
judg
posit
h
result
consist
signific
compar
fig
data
copi
standard
plasmid
also
significantli
differ
neg
control
result
show
score
system
reliabl
evalu
nt
test
result
lod
replic
posit
determin
copiesml
sequenc
data
read
per
sampl
run
sampl
detect
use
qpcr
vs
nt
perform
clinic
sampl
test
line
hospit
wuhan
soon
nt
method
establish
fig
verifi
nt
sensit
evalu
nasopharyng
swab
sampl
outpati
suspect
earli
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
epidem
februari
parallel
test
sampl
two
batch
use
nt
two
chip
qpcr
kit
fig
h
sequenc
output
data
fig
reveal
sampl
defin
posit
qpcr
recogn
nt
indic
good
intertest
concord
among
qpcrinconclus
sampl
recogn
neg
inconclus
nt
among
qpcrneg
sampl
recogn
inconclus
neg
nt
qpcr
three
posit
sampl
identifi
min
sequenc
supplementari
fig
indic
nt
could
rapidli
detect
posit
sampl
high
concentr
viru
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
evalu
posit
target
distribut
sampl
fig
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
commun
use
test
nt
viru
detect
capac
nt
min
sequenc
data
supplementari
tabl
herein
develop
nt
method
abl
simultan
detect
addit
type
respiratori
virus
within
h
lod
copiesml
least
h
sequenc
data
detect
region
compos
fragment
cover
nearli
kb
genom
result
markedli
higher
sensit
accuraci
qpcr
kit
current
clinic
use
notabl
suspect
sampl
neg
inconclus
qpcr
test
identifi
posit
nt
moreov
nt
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
enabl
detect
viru
mutat
particular
detect
nucleotid
mutat
undetect
genom
data
current
gisaid
databas
although
silent
mutat
presenc
suggest
viru
may
undergon
mutat
spread
process
addit
nt
verifi
capabl
detect
five
pread
respiratori
virus
singl
detect
method
also
detect
coinfect
case
human
influenza
viru
use
clinic
specimen
illustr
abil
nt
detect
distinguish
respiratori
virus
togeth
find
indic
nt
highli
suitabl
detect
variat
monitor
current
epidem
directli
clinic
sampl
sameday
turnaround
result
time
write
epidem
remain
sever
accur
rapid
comprehens
nucleic
acid
detect
method
need
allow
patient
suspect
infect
isol
treat
soon
possibl
accur
confirm
whether
patient
cure
prevent
continu
epidem
spread
caus
misdiagnosi
lod
nt
shown
low
copiesml
render
sensit
qpcr
eg
kit
describ
lod
copiesml
thu
like
decreas
high
falseneg
rate
plagu
current
detect
method
addit
detect
coinfect
may
allow
prevent
diseas
progress
mild
sever
might
use
inform
clinic
treatment
overal
nt
combin
sensit
broad
detect
rang
sameday
rapid
turnaround
time
variat
monitor
low
cost
compar
wholegenom
sequenc
make
suitabl
method
detect
suspect
viral
infect
effect
diagnos
method
moreov
minion
smallest
oxford
nanopor
sequenc
smaller
cellphon
equip
laptop
comput
data
process
thu
allow
rapid
perform
nt
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
variou
environ
low
equip
cost
data
analysi
cloud
analysi
may
also
introduc
highthroughput
detect
sever
limit
current
nt
method
note
design
amplifi
fragment
bp
length
constitut
suitabl
length
detect
nanopor
platform
nucleic
acid
fragment
bp
readili
detect
therebi
sensit
nt
detect
target
fragment
highli
degrad
nucleic
acid
may
hamper
addit
although
turnaround
time
nt
longer
qpcr
possibl
nucleic
acid
detect
method
eg
sherlock
h
consid
accept
clinic
use
moreov
nt
alreadi
fastest
strategi
base
sequenc
method
date
detect
variat
directli
clinic
sampl
wherea
detect
throughput
nt
high
present
nt
method
integr
wide
use
autom
semiautom
platform
improv
detect
throughput
futur
addit
pcr
includ
nt
process
involv
open
lid
pcr
tube
may
caus
mutual
contamin
sampl
howev
situat
also
inevit
current
nucleic
acid
detect
method
eg
qpcr
nucleic
acid
detect
scheme
eg
sherlock
toehold
switch
biosensor
also
involv
pcr
introduct
integr
system
seal
devic
microfluid
may
avoid
situat
present
process
sequenc
data
analysi
interpret
result
matur
nevertheless
number
test
sampl
increas
addit
test
result
collect
process
continu
optim
obtain
accur
result
notabl
comparison
nt
qpcr
result
indic
high
falseneg
rate
latter
result
highlight
need
extrem
vigil
patient
misdiagnosi
includ
patient
admit
discharg
lead
spread
epidem
greater
public
health
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
threat
suspect
neg
result
report
current
qpcr
method
subject
accur
method
secondari
confirm
consid
nt
recommend
solut
current
avail
situat
coinfect
report
previou
studi
also
warrant
continu
attent
base
current
central
treatment
strategi
lack
screen
multipl
virus
may
lead
largescal
crosscontamin
confound
clinic
diagnosi
treatment
altern
nt
repres
effect
strategi
rapid
accur
distinguish
multipl
respiratori
virus
speci
subtyp
level
could
appli
spot
check
central
clinic
final
nt
method
respiratori
viru
detect
might
extend
detect
virus
pathogen
design
addit
primer
panel
n
select
templat
design
seri
endtoend
primer
region
encod
select
templat
design
nest
primer
higher
sensit
detect
primer
design
use
onlin
primerblast
http
wwwncbinlmnihctoolsprimerblast
specif
primer
verifi
homo
sapien
fungi
bacteria
final
download
select
n
rdrp
e
gene
sequenc
sarsrel
virus
avail
genbank
januari
access
multipl
sequenc
align
sarsrel
virus
perform
use
clustal
w
version
gene
individu
align
use
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
insilico
evalu
specif
design
primer
specif
primer
collect
form
primer
panel
copiesml
four
replic
concentr
nt
librari
prepar
describ
sequenc
use
minion
min
min
h
h
h
sequenc
data
process
describ
viru
identif
lod
determin
concentr
read
map
significantli
higher
neg
control
replic
nt
detect
method
target
gene
amplifi
use
respiratori
viru
primer
panel
reaction
system
total
nucleic
acid
primer
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
phusion
u
multiplex
pcr
master
mix
thermo
fisher
usa
amplif
perform
thermocycl
biorad
usa
use
follow
procedur
cycl
min
cycl
follow
final
elong
step
min
product
firststep
purifi
ampur
bead
beckman
coulter
usa
elut
trisedta
te
buffer
eluat
use
secondstep
pcr
barcod
primer
phusion
u
multiplex
pcr
master
mix
barcod
sequenc
nanopor
pcr
barcod
kit
uk
primer
oligo
fulllength
n
gene
fragment
synthes
genscript
china
product
secondstep
pcr
differ
sampl
pool
equal
mass
te
buffer
assay
batch
neg
control
sequenc
librari
construct
use
ligat
kit
oxford
nanopor
uk
sequenc
use
oxford
nanopor
minion
gridion
nanopor
sequenc
data
process
basecal
qualiti
assess
minion
sequenc
data
perform
use
high
accuraci
mode
guppi
v
softwar
gridion
process
conduct
use
minknow
v
integr
instrument
e
site
target
kit
cfdaapprov
kit
two
target
site
use
studi
kit
cfdaapprov
kit
three
target
site
use
studi
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
